Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis C

  Free Subscription

Articles published in
Lancet
    October 2020
  1. WARD JW
    The Nobel Prize for discovery of HCV is a call to end hepatitis.
    Lancet. 2020 Oct 29. pii: S0140-6736(20)32282.
    >> Share

  2. BURKI T
    Nobel Prize for hepatitis C virus discoverers.
    Lancet. 2020;396:1058.
    >> Share

    July 2020
  3. DEVI S
    Ukrainian health authorities adopt hepatitis C project.
    Lancet. 2020;396:228.
    >> Share

    October 2019
  4. FARRELL M, Martin NK, Stockings E, Borquez A, et al
    Responding to global stimulant use: challenges and opportunities.
    Lancet. 2019 Oct 21. pii: S0140-6736(19)32230.
    >> Share

  5. SPEARMAN CW, Dusheiko GM, Hellard M, Sonderup M, et al
    Hepatitis C.
    Lancet. 2019;394:1451-1466.
    >> Share

    February 2019
  6. HOLMES JA, Rutledge SM, Chung RT
    Direct-acting antiviral treatment for hepatitis C.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32326.
    >> Share

  7. CARRAT F, Fontaine H, Dorival C, Simony M, et al
    Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32111.
    >> Share

    January 2019
  8. HEFFERNAN A, Cooke GS, Nayagam S, Thursz M, et al
    Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model.
    Lancet. 2019 Jan 28. pii: S0140-6736(18)32277.
    >> Share

  9. WIKTOR S
    How feasible is the global elimination of HCV infection?
    Lancet. 2019 Jan 28. pii: S0140-6736(18)32750.
    >> Share

    December 2018
  10. WILLIAMS R, Alexander G, Aspinall R, Batterham R, et al
    Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2018;392:2398-2412.
    >> Share

    July 2018
  11. WEBSTER P
    Hepatitis C treatment in Guatemala: the struggle for access.
    Lancet. 2018;392:269-270.
    >> Share

  12. THE LANCET
    Transforming treatment for hepatitis C.
    Lancet. 2018;392:254.
    >> Share

    June 2018
  13. WEBSTER P
    Hepatitis C-infected organ transplants offer hope.
    Lancet. 2018;391:2485.
    >> Share

    March 2018
  14. MOIN A, Fatima H, Qadir TF
    Tackling hepatitis C-Pakistan's road to success.
    Lancet. 2018;391:834-835.
    >> Share

  15. WANDELER G, Coffie PA, Kuniholm MH, Ocama P, et al
    Issues with measuring hepatitis prevalence in resource-limited settings.
    Lancet. 2018;391:835-836.
    >> Share

    November 2017
  16. GARTNER C, Miller A, Bonevski B
    Extending survival for people with hepatitis C using tobacco dependence treatment.
    Lancet. 2017;390:2033.
    >> Share

    September 2017
  17. GARCIA-TARDON N, Gresnigt TM, Fofanah AB, Grobusch MP, et al
    Hepatitis B and C in Tonkolili Province, Sierra Leone.
    Lancet. 2017;390:1485.
    >> Share

    July 2017
  18. WIKTOR SZ, Scott JD
    What is the impact of treatment for hepatitis C virus infection?
    Lancet. 2017;390:107-109.
    >> Share

  19. DOYLE JS, Thompson AJ, Higgs P, Stoove M, et al
    New hepatitis C antiviral treatments eliminate the virus.
    Lancet. 2017 Jul 6. pii: S0140-6736(17)31817.
    >> Share

    February 2017
  20. EKSER B, Mangus RS
    Spontaneous bacterial peritonitis.
    Lancet. 2017;389:735.
    >> Share

    January 2017
  21. VAN DER REE MH, de Vree JM, Stelma F, Willemse S, et al
    Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
    Lancet. 2017 Jan 10. pii: S0140-6736(16)31715.
    >> Share

  22. ZEISEL MB, Baumert TF
    Clinical development of hepatitis C virus host-targeting agents.
    Lancet. 2017 Jan 10. pii: S0140-6736(17)30043.
    >> Share

    December 2016
  23. LIVINEC B
    Estimating the burden of hepatitis.
    Lancet. 2016;388:2738-2739.
    >> Share

    November 2016
  24. GHINEA N, Lipworth W, Day R, Hill A, et al
    Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries.
    Lancet. 2016 Nov 3. pii: S0140-6736(16)32051.
    >> Share

    September 2016
  25. MOHAMMADI D
    Lasker Foundation announces award winners for 2016.
    Lancet. 2016;388:1144-5.
    >> Share

  26. PIROTH L, Rabaud C, Rey D, Schmit JL, et al
    Hepatitis C: the path towards effective universal therapy.
    Lancet. 2016;388:1051-2.
    >> Share

    July 2016
  27. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    >> Share

  28. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016